World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4181)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

296

WORD

150

HTML

2336

Figures (1-3)

233

Tables (1-1)

176

Sum=3191

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

364

Download

626

Sum=990

Jun 16, 2021 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Tan YW, Chen L, Zhou XB. Efficacy of artificial liver support system in severe immune-associated hepatitis caused by camrelizumab: A case report and review of the literature. World J Clin Cases 2021; 9(17): 4415-4422 [PMID: 34141809 DOI: 10.12998/wjcc.v9.i17.4415]
URL:	https://www.wjgnet.com/1948-5182/full/v9/i17/4415.htm

Number	Citing Articles
1	You-Wen Tan, Li-Ping Liu, Kai Zhang. Double plasma molecular adsorption system for Stevens–Johnson syndrome/toxic epidermal necrolysis: A case report. World Journal of Clinical Cases 2024; 12(7): 1371-1377 doi: 10.12998/wjcc.v12.i7.1371 Abstract(94) \| Core Tip(77) \| Full Article(HTML)(606) \| Full Article with Cover (PDF)-7017K(50) \| Audio-863K(0) \| Peer-Review Report-171K(11) \| Answering Reviewers-105K(10) \| Full Article (PDF)-6779K(68) \| Full Article (XML)-50K(16) \| Times Cited (1) \| Total Visits (1362) \| Open
2	Camrelizumab. Reactions Weekly 2022; 1894(1): 87 doi: 10.1007/s40278-022-10200-9
3	Oluwatoyosi A. Onwuemene, Chizoba I. Nnoruka, Christopher J. Patriquin, Laura S. Connelly‐Smith. Therapeutic plasma exchange in the management of immune checkpoint inhibitor‐associated immune‐related adverse effects: A review. Transfusion 2022; 62(11): 2370 doi: 10.1111/trf.17114
4	Kefan Chen, Junhao He, Jing Xu, Jie Chen. Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1088741
5	Yan Lei, Yuling Liang, Xuemei Zhang, Xiaohua Wang, Yu Zhang, Yuk Ming Chan, Chun Tang, Zhihua Zheng. Alternating therapeutic plasma exchange (TPE) with double plasma molecular adsorption system (DPMAS) for the treatment of fulminant hepatic failure (FHF). Clinical Case Reports 2021; 9(12) doi: 10.1002/ccr3.5220
6	Hui Xing, Yang Wang, Bo Qu, Qiang Wei, Cuihua Li, Chao Pan, Hui Li. The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity. Translational Oncology 2023; 28: 101619 doi: 10.1016/j.tranon.2023.101619
7	Ying Liu, Lihua Zheng, Wenxiong Xu, Qihuan Xu, Xinhua Li, Qu Lin, Lu Wang, Jing Lai. Efficacy of Plasma Exchange and a Double-Plasma Molecular Absorption System for Treating Immune Checkpoint Inhibitor-Related Hepatitis. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-137153